Utilities of traditional and novel biomarkers in the management of acute kidney injury

References

• Hoste EAJ, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med. 2008;36(Suppl.):S146–S151.
   PubMedGoogle Scholar
• Hoste EAJ, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411–1423.
   PubMed Web of Science ®Google Scholar
• Sawhney S, Marks A, Fluck N, et al. Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study. Am J Kidney Dis. 2017;69(1):18–28.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Kellum JA, Ronco C, et al. Acute kidney injury in sepsis. Intensive Care Med. 2017;43(6):816–828.
   PubMed Web of Science ®Google Scholar
• Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.
   PubMed Web of Science ®Google Scholar
• Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care. 2013;17(1):204.
   PubMed Web of Science ®Google Scholar
• Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71(10):1028–1035.
   PubMed Web of Science ®Google Scholar
• Toda Y, Sugimoto K. AKI after pediatric cardiac surgery for congenital heart diseases – recent developments in diagnostic criteria and early diagnosis by biomarkers. J Intensive Care. 2017;5:49.
   PubMed Web of Science ®Google Scholar
• Barasch J, Zager R, Bonventre JV. Acute kidney injury: a problem of definition. Lancet. 2017;389(10071):779–781.
   PubMed Web of Science ®Google Scholar
• Koeze J, Keus F, Dieperink W, et al. Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria. BMC Nephrol. 2017;18(1):70.
   PubMedGoogle Scholar
• Inker LA, Astor BC, Fox CH, et al. KDOQI US Commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–735.
   PubMed Web of Science ®Google Scholar
• Belcher JM, Garcia-Tsao G, Sanyal AJ, et al. Urinary biomarkers and progression of AKI in patients with cirrhosis. Clin J Am Soc Nephrol. 2014;9(11):1857–1867.
   PubMed Web of Science ®Google Scholar
• Perazella MA, Coca SG, Kanbay M, et al. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol. 2008;3(6):1615–1619.
   PubMed Web of Science ®Google Scholar
• Kellum J. A, Lameire N, Aspelin P, et al. Summary of recommendation statements. Kidney Int Suppl. 2012;2:8–12.
   Web of Science ®Google Scholar
• Perazella MA, Coca SG, Hall IE, et al. Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol. 2010;5(3):402–408.
   PubMed Web of Science ®Google Scholar
• Koyner JL, Davison DL, Brasha-Mitchell E, et al. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol. 2015;26(8):2023–2031.
   PubMed Web of Science ®Google Scholar
• Matsuura R, Komaru Y, Miyamoto Y, et al. Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels. Ann Intensive Care. 2018;8(1):8–17.
   PubMedGoogle Scholar
• Wang JJ, Chi NH, Huang TM, et al. Urinary biomarkers predict advanced acute kidney injury after cardiovascular surgery. Crit Care. 2018;22:1–13.
   PubMed Web of Science ®Google Scholar
• Malhotra R, Siew ED. Biomarkers for the early detection and prognosis of acute kidney injury. Clin J Am Soc Nephrol. 2017;12(1):149–173.
   PubMed Web of Science ®Google Scholar
• Bonventre JV, Vaidya VS, Schmouder R, et al. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol. 2010;28(5):436–440.
   PubMed Web of Science ®Google Scholar
• Pickering JW, Endre ZH. Bench to bedside: the next steps for biomarkers in acute kidney injury. Am J Physiol Renal Physiol. 2016;311(4):F717–F721.
   PubMed Web of Science ®Google Scholar
• Devarajan P. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology. 2010;15(4):419–428.
   PubMed Web of Science ®Google Scholar
• Haase-Fielitz A, Bellomo R, Devarajan P, et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant. 2009;24(11):3349–3354.
   PubMed Web of Science ®Google Scholar
• Haase M, Devarajan P, Haase-Fielitz A, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol. 2011;57(17):1752–1761.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Noiri E, Ono Y, et al. Renal l-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol. 2007;18(11):2894–2902.
   PubMed Web of Science ®Google Scholar
• Susantitaphong P, Siribamrungwong M, Doi K, et al. Performance of urinary liver-type fatty acid–binding protein in acute kidney injury: a meta-analysis. Am J Kidney Dis. 2013;61(3):430–439.
   PubMed Web of Science ®Google Scholar
• Manabe K, Kamihata H, Motohiro M, et al. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury. Eur J Clin Invest. 2012;42(5):557–563.
   PubMed Web of Science ®Google Scholar
• Hishikari K, Hikita H, Nakamura S, et al. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of acute kidney injury in patients with acute decompensated heart failure. Cardiorenal Med. 2017;7(4):267–275.
   PubMed Web of Science ®Google Scholar
• Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17(1):R25.
   PubMed Web of Science ®Google Scholar
• Bihorac A, Chawla LS, Shaw AD, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med. 2014;189(8):932–939.
   PubMed Web of Science ®Google Scholar
• Hoste EAJ, McCullough PA, Kashani K, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant. 2014;29(11):2054–2061.
   PubMed Web of Science ®Google Scholar
• Price PM, Safirstein RL, Megyesi J. The cell cycle and acute kidney injury. Kidney Int. 2009;76(6):604–613.
   PubMed Web of Science ®Google Scholar
• Johnson ACM, Zager RA. Mechanisms underlying increased TIMP2 and IGFBP7 urinary excretion in experimental AKI. J Am Soc Nephrol. 2018;29(8):2157–2167.
   PubMed Web of Science ®Google Scholar
• Koyner JL, Shaw AD, Chawla LS, et al. Tissue inhibitor metalloproteinase-2 (TIMP-2)*IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol. 2015;26(7):1747–1754.
   PubMed Web of Science ®Google Scholar
• Pilarczyk K, Edayadiyil-Dudasova M, Wendt D, et al. Urinary [TIMP-2]*[IGFBP7] for early prediction of acute kidney injury after coronary artery bypass surgery. Ann Intensive Care. 2015;5(1):50–60.
   PubMedGoogle Scholar
• Levante C, Ferrari F, Manenti C, et al. Routine adoption of TIMP2 and IGFBP7 biomarkers in cardiac surgery for early identification of acute kidney injury. Int J Artif Organs. 2017;40(12):714–718.
   PubMed Web of Science ®Google Scholar
• Dusse F, Edayadiyil-Dudásova M, Thielmann M, et al. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers. BMC Anesthesiol. 2015;16(1):76–87.
   Web of Science ®Google Scholar
• Wetz AJ, Richardt EM, Wand S, et al. Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery? Crit Care. 2015;19(1):3–9.
   PubMedGoogle Scholar
• Daubin D, Cristol JP, Dupuy AM, et al. Urinary biomarkers IGFBP7 and TIMP-2 for the diagnostic assessment of transient and persistent acute kidney injury in critically ill patients. Sands JM, editor. PLoS ONE. 2017;12(1):e0169674.
   PubMed Web of Science ®Google Scholar
• Ronco C, Rizo-Topete L, Serrano-Soto M, et al. Pro: prevention of acute kidney injury: time for teamwork and new biomarkers. Nephrol Dial Transplant. 2017;32(3):408–413.
   PubMed Web of Science ®Google Scholar
• Ehrmann S, Quartin A, Hobbs BP, et al. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. 2017;43(6):785–794.
   PubMed Web of Science ®Google Scholar
• Göcze I, Jauch D, Götz M, et al. Biomarker-guided Intervention to prevent acute kidney injury after major surgery. Ann Surg. 2018;267(6):1013–1020.
   PubMed Web of Science ®Google Scholar
• Ng LL, Squire IB, Jones DJL, et al. Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure: a GREAT Network Study. J Am Coll Cardiol. 2017;69(1):56–69.
   PubMed Web of Science ®Google Scholar
• Marino R, Struck J, Hartmann O, et al. Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department. J Nephrol. 2015;28(6):717–724.
   PubMed Web of Science ®Google Scholar
• Kim H, Hur M, Lee S, et al. Proenkephalin, neutrophil gelatinase-associated lipocalin, and estimated glomerular filtration rates in patients with sepsis. Ann Lab Med. 2017;37(5):388–397.
   PubMed Web of Science ®Google Scholar
• Caironi P, Latini R, Struck J, et al. Circulating proenkephalin, acute kidney injury, and its improvement in patients with severe sepsis or shock. Clin Chem. 2018;64(9):1361–1369.
   PubMed Web of Science ®Google Scholar
• Gayat E, Touchard C, Hollinger A, et al. Back-to-back comparison of penKID with NephroCheck® to predict acute kidney injury at admission in intensive care unit: a brief report. Crit Care. 2018;22(1):24.
   PubMedGoogle Scholar
• Razzaque MS. The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol. 2009;5(11):611–619.
   PubMed Web of Science ®Google Scholar
• Isakova T. Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens. 2012;21(3):334–340.
   PubMed Web of Science ®Google Scholar
• Leaf DE, Wolf M, Stern L. Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury. Nephrol Dial Transplant. 2010;25(4):1335–1337.
   PubMed Web of Science ®Google Scholar
• Christov M. Fibroblast growth factor 23 in acute kidney injury. Curr Opin Nephrol Hypertens. 2014;23(4):340–345.
   PubMed Web of Science ®Google Scholar
• Leaf DE, Christov M, Jüppner H, et al. Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery. Kidney Int. 2016;89(4):939–948.
   PubMed Web of Science ®Google Scholar
• Leaf DE, Siew ED, Eisenga MF, et al. Fibroblast growth factor 23 associates with death in critically ill patients. Clin J Am Soc Nephrol. 2018;13(4):531–541.
   PubMed Web of Science ®Google Scholar
• Christov M, Neyra JA, Gupta S, et al. Fibroblast growth factor 23 and Klotho in AKI. Semin Nephrol. 2019;39(1):57–75.
   PubMed Web of Science ®Google Scholar
• Ebbing J, Mathia S, Seibert FS, et al. Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder. World J Urol. 2014;32(6):1485–1492.
   PubMed Web of Science ®Google Scholar
• Heller F, Frischmann S, Grunbaum M, et al. Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury. Clin J Am Soc Nephrol. 2011;6(10):2347–2355.
   PubMed Web of Science ®Google Scholar
• Seibert FS, Pagonas N, Arndt R, et al. Calprotectin and neutrophil gelatinase-associated lipocalin in the differentiation of pre-renal and intrinsic acute kidney injury. Acta Physiol. 2013;207(4):700–708.
   PubMed Web of Science ®Google Scholar
• Chang C-H, Yang C-H, Yang H-Y, et al. Urinary biomarkers improve the diagnosis of intrinsic acute kidney injury in coronary care units. Medicine (Baltimore). 2015;94(40):e1703.
   PubMed Web of Science ®Google Scholar
• Seibert FS, Rosenberger C, Mathia S, et al. Urinary calprotectin differentiates between prerenal and intrinsic acute renal allograft failure. Transplantation. 2017;101(2):387–394.
   PubMed Web of Science ®Google Scholar
• Pawlak K, Mysliwiec M, Pawlak D. Endocan — the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease. Clin Biochem. 2015;48(6):425–430.
   PubMed Web of Science ®Google Scholar
• Azimi A. Could “calprotectin” and “endocan” serve as “troponin of nephrologists”? Med Hypotheses. 2017;99:29–34.
   PubMed Web of Science ®Google Scholar
• Kashani K, Cheungpasitporn W, Ronco C. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption. Clin Chem Lab Med. 2017;55(8):1074–1089.
   PubMed Web of Science ®Google Scholar
• Van Biesen W. Con: cautionary tales and reservations about the adoption of new technologies and biomarkers for the management of acute kidney injury. Nephrol Dial Transplant. 2017;32(3):414–417.
   PubMed Web of Science ®Google Scholar
• Lameire N, Vanmassenhove J, Van Biesen W, et al. The cell cycle biomarkers: promising research, but do not oversell them. Clin Kidney J. 2016;9(3):353–358.
   PubMed Web of Science ®Google Scholar
• Park SK, Hur M, Kim E, et al. Risk factors for acute kidney injury after congenital cardiac surgery in infants and children: a retrospective observational study. PLoS One. 2016;11(11):e0166328.
   PubMed Web of Science ®Google Scholar
• Lex DJ, Tóth R, Cserép Z, et al. A comparison of the systems for the identification of postoperative acute kidney injury in pediatric cardiac patients. Ann Thorac Surg. 2014;97(1):202–210.
   PubMed Web of Science ®Google Scholar
• Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697–711.
   PubMed Web of Science ®Google Scholar
• Greenberg JH, Parikh CR. Biomarkers for diagnosis and prognosis of AKI in children: one size does not fit all. Clin J Am Soc Nephrol. 2017;12(9):1551–1557.
   PubMed Web of Science ®Google Scholar
• Ruf B, Bonelli V, Balling G, et al. Intraoperative renal near-infrared spectroscopy indicates developing acute kidney injury in infants undergoing cardiac surgery with cardiopulmonary bypass: a case-control study. Crit Care. 2015;19(1):27–37.
   PubMedGoogle Scholar
• Adams PS, Vargas D, Baust T, et al. Associations of perioperative renal oximetry via near-infrared spectroscopy, urinary biomarkers, and postoperative acute kidney injury in infants after congenital heart surgery: should creatinine continue to be the gold standard? Pediatr Crit Care Med. 2019;20(1):27–37.
   PubMed Web of Science ®Google Scholar
• Haines RW, Fowler AJ, Kirwan CJ, et al. The incidence and associations of acute kidney injury in trauma patients admitted to critical care: a systematic review and meta-analysis. J Trauma Acute Care Surg. 2019;86(1):141–147.
   PubMed Web of Science ®Google Scholar
• Moreira MA, Irigoyen MC, Saad KR, et al. N-acetylcysteine reduces the renal oxidative stress and apoptosis induced by hemorrhagic shock. J Surg Res. 2016; 203(1):113–120.
   PubMed Web of Science ®Google Scholar
• Shaheen A, Crandall M, Nicolson N, et al. Abdominal compartment syndrome in trauma patients: new insights for predicting outcomes. J Emerg Trauma Shock. 2016;86:141–147.
   Google Scholar
• Holodinsky JK, Roberts DJ, Ball CG, et al. Risk factors for intra-abdominal hypertension and abdominal compartment syndrome among adult intensive care unit patients: a systematic review and meta-analysis. Crit Care. 2013;17(5):R249–R263.
   PubMed Web of Science ®Google Scholar
• Spahn DR, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23:98–171.
   PubMed Web of Science ®Google Scholar
• Hoste EAJ, De Corte W. Implementing the kidney disease: improving global outcomes/acute kidney injury guidelines in ICU patients. Curr Opin Crit Care. 2013;19(6):544–553.
   PubMed Web of Science ®Google Scholar
• Schanz M, Wasser C, Allgaeuer S, et al. Urinary [TIMP-2]•[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department. Nephrol Dial Transplant. 2019;19:1902–1909.
   Google Scholar